Click-based synthesis of triazolobithiazole ΔF508-CFTR correctors for cystic fibrosis

被引：16
|
作者：
Donald, Michael B. [3 ]
Rodriguez, Kevin X. [3 ]
Shay, Hannah [3 ]
Phuan, Puay-Wah [1 ,2 ]
Verkman, A. S. [1 ,2 ]
Kurth, Mark J. [1 ,2 ]
机构：
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA
[3] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2012年 / 20卷 / 17期
基金：
美国国家卫生研究院; 美国国家科学基金会;
关键词：
CuAAC; Triazolobithiazole; Cystic fibrosis; CF corrector; TRANSMEMBRANE CONDUCTANCE REGULATOR;
D O I：
10.1016/j.bmc.2012.06.046
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Copper catalyzed azide-alkyne cycloaddition (CuAAC) chemistry is reported for the construction of previously unknown 5-(1H-1,2,3-triazol-1-yl)-4,5'-bithiazoles from 2-bromo-1-(thiazol-5-yl)ethanones. These novel triazolobithiazoles are shown to have cystic fibrosis (CF) corrector activity and, compared to the benchmark bithiazole CF corrector corr-4a, improved log P values (4.5 vs 5.96). (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码：5247 / 5253
页数：7
相关论文
共 50 条
  • [1] LUNG PARTITIONING OF ΔF508-CFTR CORRECTORS
    Ferkany, J. W.
    Krouse, M. E.
    Kolodziej, A. F.
    Fitzpatrick, R.
    Cole, B. M.
    PEDIATRIC PULMONOLOGY, 2015, 50 : 216 - 216
  • [2] Isoxazolopyrimidines as Novel ΔF508-CFTR Correctors
    Yu, Gui Jun
    Yang, Baoxue
    Verkman, A. S.
    Kurth, Mark J.
    SYNLETT, 2010, (07) : 1063 - 1066
  • [3] DISCOVERY AND DEVELOPMENT OF NOVEL ΔF508-CFTR CORRECTORS
    Patron, T.
    Valdez, R.
    Bhatt, P.
    Deshpande, A.
    Krouse, M.
    Barsukov, G.
    Handley, K.
    Finnegan, D.
    Nugent, R.
    Zawistoski, M.
    Shang, H.
    Kanawade, A.
    Li, T.
    Sui, J.
    Kwok, I
    Mai, V
    Miranda, L.
    Lesser, A.
    Smith, P.
    Layer, E.
    Kaczmarek, S.
    Kolodziej, A. F.
    Fitzpatrick, R.
    Cole, B. M.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 224 - 224
  • [4] An overview on chemical structures as ΔF508-CFTR correctors
    Spano, Virginia
    Montalbano, Alessandra
    Carbone, Anna
    Scudieri, Paolo
    Galietta, Luis J. V.
    Barraja, Paola
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 180 : 430 - 448
  • [5] EVALUATION OF HISTONE DEACETYLASE INHIBITORS AS CORRECTORS OF ΔF508-CFTR
    Tomati, V
    Sondo, E.
    Pedemonte, N.
    Caci, E.
    Galietta, L. J.
    PEDIATRIC PULMONOLOGY, 2010, : 313 - 313
  • [6] COMPREHENSIVE SPECTRUM OF ACTIVITY ANALYSIS FOR ΔF508-CFTR CORRECTORS
    Pyle, L. C.
    Fan, L.
    Fortenberry, J.
    Tang, L.
    Backer, K.
    Mazur, M.
    Clancy, J. P.
    Sorscher, E. J.
    Rowe, S. M.
    PEDIATRIC PULMONOLOGY, 2009, : 291 - 291
  • [7] Fluorinated ΔF508-CFTR correctors and potentiators for PET imaging
    Davison, Holly R.
    Solano, Danielle M.
    Phuan, Puay-Wah
    Verkman, A. S.
    Kurth, Mark J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (04) : 1602 - 1605
  • [8] PROGRESS TOWARD GENERATING A ΔF508-CFTR CYSTIC FIBROSIS FERRET MODEL
    Yan, Z.
    Lei-Butters, D.
    Sun, X.
    Yi, Y.
    Fisher, J. T.
    Engelhardt, J. F.
    PEDIATRIC PULMONOLOGY, 2009, : 284 - 284
  • [9] Design and synthesis of a hybrid potentiator-corrector agonist of the cystic fibrosis mutant protein ΔF508-CFTR
    Mills, Aaron D.
    Yoo, Choong
    Butler, Jeffrey D.
    Yang, Baoxue
    Verkman, A. S.
    Kurth, Mark J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) : 87 - 91
  • [10] The effects of curcumin on the expression of ΔF508-CFTR in gastrointestinal epithelia of a cystic fibrosis mouse model
    Weiner, SA
    Pearson, MA
    Bruscia, E
    Krause, D
    Geibel, JP
    Caplan, MJ
    Egan, ME
    PEDIATRIC RESEARCH, 2004, 55 (04) : 600A - 600A
12345